Alivus Life Sciences Incorporates Wholly Owned Subsidiary in Brazil

Alivus Life Sciences Ltd has announced the incorporation of its wholly owned subsidiary, Alivus Life Sciences Do Brasil Ltda., in Sao Paulo, Brazil, on September 15, 2026. The subsidiary has an authorized capital of R$ 500,000.00. This move is a strategic expansion into the Brazilian market within the pharmaceuticals industry. The incorporation was approved by the Federative Republic of Brazil National Registrar of Legal Entities. The company will subscribe to 100% of the subsidiary's share capital, amounting to R$ 500,000.00, which is considered a cash consideration and not a related party transaction.